Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study.

van Vliet IM, den Boer JA, Westenberg HG, Pian KL.

J Clin Psychiatry. 1997 Apr;58(4):164-8.

PMID:
9164427
2.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
3.

Role of serotonin drugs in the treatment of social phobia.

Tancer ME, Uhde TW.

J Clin Psychiatry. 1997;58 Suppl 5:50-4. Review.

PMID:
9184626
4.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
5.

Treatment of social phobia with benzodiazepines.

Davidson JR, Tupler LA, Potts NL.

J Clin Psychiatry. 1994 Jun;55 Suppl:28-32. Review.

PMID:
8077166
6.

Buspirone in the long-term treatment of generalized anxiety disorder.

Feighner JP.

J Clin Psychiatry. 1987 Dec;48 Suppl:3-6. Review.

PMID:
3320034
7.
8.

A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia).

Versiani M.

World J Biol Psychiatry. 2000 Jan;1(1):27-33. Review.

PMID:
12607230
9.

Recent advances in the psychopharmacology of social phobia.

Den Boer JA, Van Vliet IM, Westenberg HG.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jul;18(4):625-45. Review.

PMID:
7938556
10.

Reversible monoamine oxidase-A inhibitors in social phobia.

Liebowitz MR, Schneier F, Gitow A, Feerick J.

Clin Neuropharmacol. 1993;16 Suppl 2:S83-8. Review.

PMID:
8313403
11.

The pharmacotherapy of social phobia.

Pollack MH, Gould RA.

Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:71-5. Review.

PMID:
8923113
12.

[Buspirone: a new non-benzodiazepine anxiolytic drug].

Honorato J, Catalán M.

Rev Clin Esp. 1990 Apr;186(6):286-91. Review. Spanish.

PMID:
2203117
13.

Calcium channel blockers for anxiety disorders?

Balon R, Ramesh C.

Ann Clin Psychiatry. 1996 Dec;8(4):215-20. Review.

PMID:
8986318
14.

Efficacy of buspirone in alcohol dependence: a review.

Malec TS, Malec EA, Dongier M.

Alcohol Clin Exp Res. 1996 Aug;20(5):853-8. Review.

PMID:
8865960
15.

Quality of life in anxiety and social phobia.

Bech P, Angst J.

Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:97-100. Review.

PMID:
8923117
16.

Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.

Paterson NE, Vocci F, Sevak RJ, Wagreich E, London ED.

Am J Drug Alcohol Abuse. 2014 Jan;40(1):1-9. doi: 10.3109/00952990.2013.858723. Review.

PMID:
24359505
17.

Issues in the design of trials for the evaluation of psychopharmacological treatments for social phobia.

Liebowitz MR, Heimberg RG.

Int Clin Psychopharmacol. 1996 Jun;11 Suppl 3:49-53. Review.

PMID:
8923110
18.

Buspirone--an alternative drug for anxiety?

[No authors listed]

Drug Ther Bull. 1989 Apr 3;27(7):27-8. Review. No abstract available.

PMID:
2519143

Supplemental Content

Support Center